Interferon-gamma - Inducible inflammation: Contribution to aging and aging-associated psychiatric disorders

Aging and Disease

Volumn 2, Issue 6, 2011, Pages 474-486

  Oxenkrug, Gregory ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Depression; Inflammation; Insulin resistance; Interferon gamma; Kynurenines; Metabolic syndrome; Neopterin; Obesity

Indexed keywords

EID: 84874021086     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: None     Document Type: Review

References (110)

1. Vasto S, Candore G, Balistreri CR, Caruso M, Colonna-Romano G, Grimaldi MP, Listi F, Nuzzo D, Lio D, Caruso C (2007). Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev, 128:83-91.
2. Sparkman NL and Johnson RW (2008). Neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress. Neuroimmunomodulation, 15:323-330
3. Henry CJ, Huang Y, Wynne AM, Godbout JP (2009). Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines. Brain Behav Immun, 23:309-317.
4. Fridman AL and Tainsky MA (2008). Critical pathways in cellular senescence and immortalization revealed by gene expression profiling. Oncogene, 27:5975-5987.
5. Shelton RC, Claiborne J, Sidoryk-Wegrzynowicz M, Reddy R, Aschner M, Lewis DA, Mirnics K (2010). Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry, 16:751-62
6. Kim KS, Kang KW, Seu YB, Baek SH, Kim JR (2009). Interferon-gamma induces cellular senescence through p53-dependent DNA damage signaling in human endothelial cells. Mech Ageing Dev, 130:179 - 188.
7. Rodríguez MI, Escames G, López LC, López A, García JA, Ortiz F, Acuña-Castroviejo D (2007). Chronic melatonin treatment reduces the age-dependent inflammatory process in senescence-accelerated mice. J Pineal Res, 42:272-279.
8. Lio D, Scola L, Crivello A, Bonafè M, Franceschi C, Olivieri F, Colonna-Romano G, Candore G, Caruso C (2002). Allele frequencies of +874T-A single nucleotide polymorphism at the first intron of interferon-gamma gene in a group Italian centernarians. Experimental Gerontology, 37: 315-319.
9. Baran H, Cairns N, Lubec B, Lubec G (1996). Increased kynurenic acid levels and decreased brain kynurenine aminotransferase I in patients with Down syndrome. Life Sci, 58:1891-1899.
10. Sarasin-Filipowicz M, Oakeley EJ, Duong FH, Christen V, Terracciano L, Filipowicz W, Heim MH (2008). Interferon signaling and treatment outcome in chronic hepatitis C. Proc Natl Acad Sci U S A,105:7034-7039.
11. Schoedon G, Troppmair J, Adolf G, Huber C, Niederwieser A (1986). Interferon-gamma enhances biosynthesis of pterins in peripheral blood mononuclear cells by induction of GTP-cyclohydrolase I activity. J Interferon Res, 6:697-703.
12. Russo S, Kema IP, Fokkema MR, Boon JC, Willemse PH, de Vries EG, den Boer JA, Korf J (2003). Tryptophan as a link between psychopathology and somatic states. Psychosomatic Medicine, 65; 665 - 671.
13. Hochstrasser T, Ullrich C, Sperner-Unterweger B, Humpel C (2011). Inflammatory stimuli reduce survival of serotonergic neurons and induce neuronal expression of indoleamine 2,3-dioxygenase in rat dorsal raphe nucleus organotypic brain slices. Neuroscience, 16;184:128-38
14. Kanai M, Funakoshi H, Takahashi H, Hayakawa T, Mizuno S, Matsumoto K, Nakamura T (2009). Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice. Mol Brain, 2:8.
15. Ozaki Y, Edelstein M P, Duch DS (1987). The actions of interferon and antiinflammatory agents of induction of indoleamine 2,3-dioxygenase in human peripheral blood monocytes. Biochem. Biophys. Res. Commun, 144: 1147-1153.
16. Oxenkrug GF, Pomara N, McIntyre IM, Branconnier RJ, Stanley M, Gershon S (1983). Aging and cortisol resistance to supression by dexamethasone: a positive correlation. Psychiatry Research, 10:125-130.
17. Oxenkrug GF, McIntyre IM, Stanley M, Gershon S (1984). Dexamethasone suppression test: experimental model in rats and effect of age. Biol. Psychiat., 19:413-416.
18. Oxenkrug GF, McIntyre IM, Gershon S (1984). Effects of pinealectomy and aging on the serum corticosterone circadian rhythm in rats. J. Pineal Research, 1:181-185.
19. Oxenkrug GF and Gershon S (1987). Cognitive function and brain-adrenal axis activity in aging, depression and dementia. In Alzheimer's Disease and Dementia: Problems, Prospectives and Perspectives. (Altman H - ed), Plenum Press, pp: 59-66.
20. Oxenkrug GF (2010a). Tryptophan-kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: Serotonin hypothesis revisited 40 years later. Israel J Psychiatry, 47-1: 56 - 63.
21. Rongvaux AF, Andris F van Gool, Oberdan L (2003). Reconstructing eukaryotic NAD metabolism. Bioessays, 25:683-690
22. Oxenkrug GF (2010b). The extended life span of Drosophila melanogaster eye-color (white and vermilion) mutants with impaired formation of kynurenine. J Neural Transm, 117: 23 -26.
23. Schwarcz R, Pellicciari R (2002). Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther, 303:1-10
24. Kincses ZT, Toldi J, Vécsei L (2010). Kynurenines, neurodegeneration and Alzheimer's disease. J Cell Mol Med, Jul 12.
25. Lapin IP (1996). Kynurenines and anxiety. Adv Exp Med Biol, 398:191-194.
26. Lapin IP (2003). Neurokynurenines (NEKY) as common neurochemical links of stress and anxiety. Adv Exp Med Biol, 527:121-125.
27. Guilarte TR, Block LD, Wagner HN Jr (1988). The putative endogenous convulsant 3-hydroxykynurenine decreases benzodiazepine receptor binding affinity: implications to seizures associated with neonatal vitamin B-6 deficiency. Pharmacol Biochem Behav, 30:665-668.
28. Bender DA, Njagi EN, Danielian PS (1990). Tryptophan metabolism in vitamin B6-deficient mice. Br J Nutr, 63:27-36.
29. Kotaki Y, Ueda T, Mori T, Igaki S, Hattori M (1975). Abnormal tryptophan metabolism and experimental diabetes by xanthurenic acid (XA). Acta Vitaminol Enzymol, 29:236-239.
30. Meyramov G, Korchin V and Kocheryzkina N (1984). Diabetogenic activity of xanturenic acid determined by its chelating properties? Acta Vitaminol Enzymol, 6:221-228
31. Connick JH and Stone TW (1985). The role of kynurenines in diabetes mellitus. Med Hypotheses,18:371-376.
32. Melillo G, Cox DW, Biragyn A. Sheffler LA (1994). Regulation of nitric-oxide synthase mRNA expression by interferon-gamma and picolinic acid J Biol Chem, 269: 8128-813
33. Perez-Severiano F, Escalante, Rios C (1998). Nitric oxide synthase inhibition prevents acute quinolinate-induced striatal neurotoxicity. Neurochem. Res, 23: 1297-1302.
34. Oxenkrug GF, Anderson GF, Dragovic L, Blaivas M, Riederer P (1990). Circadian rhythms of human pineal melatonin, related indoles, and beta adrenoreceptors: post-mortem evaluation, J. Pineal Res, 9:1-11.
35. Oxenkrug GF and Requintina PJ (1994). Stimulation of rat pineal melatonin biosynthesis by N-acetylserotonin. Int. J. Neurosci, 77:237-241.
36. Wang Y, Lawson MA, Dantzer R, Kelley KW (2010). LPS-induced indoleamine 2,3-dioxygenase is regulated in an interferon-gamma-independent manner by a JNK signaling pathway in primary murine microglia. Brain Beh Immun, 24:201-209.
37. Lapin IP and Oxenkrug GF (1969). Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect, Lancet, 1: 32-39.
38. Kiseleva IP, Lapin IP, Prakh'e IB, Samsonova ML (1980). Different effects of kynurenines on rat liver tryptophan pyrrolase activity. Vopr Med Khim, .Jul-Aug;26(4):458-61.
39. Zawilska JB, Lorenc A, Berezinska M (2007). Regulation of serotonin N-acetyltransferase activity in the chick pineal gland by UV-A and white light: role of MK-801- and SCH 23390-sensitive retinal signals. Pharmacol Rep, 59:408-413.
40. Shimoji M, Hirayama K, Hyland K, Kapatos G (1999). GTP cyclohydrolase I gene expression in the brains of male and female hph-1 mice. J Neurochem, 72:757-764.
41. Franscini N, Blau N, Walter RB, Schaffner A, Schoedon G (2003). Critical role of interleukin-1beta for transcriptional regulation of endothelial 6-pyruvoyltetrahydropterin synthase. Arterioscler Thromb Vasc Biol, Nov 1;23(11):e50-53.
42. Schennach H, Murr C, Gächter E, Mayersbach P, Schönitzer D, Fuchs D (2002). Factors Influencing Serum Neopterin Concentrations in a Population of Blood Donors. Clinical Chemistry, 48:643-645.
43. Widner MB, Wirleitner B, Fuchs D (2002). Neopterin as a marker for immune system activation. Curr Drug Metab, 3: 175-187
44. Fuchs D, Avanzas P, Arroyo-Espliguero R, Jenny M, Consuegra-Sanchez L, Kaski JC (2009). The role of neopterin in atherogenesis and cardiovascular risk assessment. Curr Med Chem,16: 4644-4653.
45. Oxenkrug GF (2011). Interferon-gamma-inducible kynurenines/pteridines inflammation cascade: implications for aging and aging-associated medical and psychiatric disorders. J Neural Transm, 118:75 -85.
46. Pou S, Pou WS, Bredt DS, Snyder SH, Rosen GM (1992). Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem, 267:24173-24176.
47. Heinzel B, John M, Klatt P, Böhme E, Mayer B (1992). Ca+2/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J, 281:627 - 630.
48. Stewart JC, Janicki DL, Muldoon MF, Sutton-Tyrrell K, Kamarck TW (2007). Negative emotions and 3-year progression of subclinical atherosclerosis. Arch Gen Psychiatry, 64:225-233
49. Qu T, Uz T, Manev H (2000). Inflammatory 5-LOX mRNA and protein are increased in brain of aging rats. Neurbiology of Aging, 647 - 652.
50. Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV (2000). A single nucleotide polymorphism in the first intron of the human INFG gene: absolute correlation with a polymorphic CA micro marker of high INFG gene. Hum Immunol, 61: 8333-866.
51. Perrey C, Pravica V, Sinnott PJ, Hutchinson IV (1998). Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta 1 and tumour necrosis factor-alpha genes: a technical report. Transplant. Immunol, 6, 193-197.
52. Tambur AR, Ortegel JW, Ben-Ari Z, Shabtai E, Klein T, Michowiz R, Tur-Kaspa R, Mor E. (2001). Role of cytokine gene polymorphism in hepatitis C recurrence and allograft rejection among liver transplant recipients. Transplantation, 71, 1475-1480.
53. Biolo G, Amoroso A, Savoldi S, Bosutti A, Martone M, Pirulli D, Bianco F, Ulivi S, Bertok S, Artero M, Barazzoni R, Zanetti M, Grassi G, Guarnieri G, Panzetta G (2006). Association of interferon-gamma +874A polymorphism with reduced long-term inflammatory response in haemodialysis patients. Nephrol Dial Transplant, 21:1317-1322.
54. Anuradha B, Rakh SS, Ishaq M, Murthy KJ, Valluri VL (2008). Interferon-gamma Low producer genotype +874 overrepresented in Bacillus Calmette-Guerin nonresponding children. Pediatr Infect Dis J, 27:325-329.
55. Raitala A, Pertovaara M, Karjalainen J, Oja SS, Hurme M (2005). Association of interferon-gamma +874(T/A) single nucleotide polymorphism with the rate of tryptophan catabolism in healthy individuals. Scand J Immunol,61:387-390
56. Oxenkrug G, Perianayagam, Summergrad P (2011). Interferon-gamma (+874) single nucleotide polymorphism and human plasma neopterin levels. American Journal of Neuroprotection and Neuroregeneration, in press.
57. Bending D, Newland S, Krejcí A, Phillips JM, Bray S, Cooke A (2011). Epigenetic changes at Il12rb2 and Tbx21 in relation to plasticity behavior of Th17 cells. J Immunol, 186:3373-33825
58. Kikuchi H, Kuribayashi F, Kiwaki N, Takami Y, Nakayama T (2011). GCN5 regulates the superoxide-generating system in leukocytes via controlling gp91-phox gene expression. J Immunol, 186:3015-3022.
59. Bollati V, Baccarelli A, Sartori S, Tarantini L, Motta V, Rota F, Costa G (2010). Epigenetic effects of shiftwork on blood DNA methylation. Chronobiol Int, 2 7:1093-1104.
60. Capuron L and Miller AH (2011). Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther,. 130:226-238.
61. Henry CJ, Huang Y, Wynne A, Hanke M, Himler J, Bailey MT, Sheridan JF, Godbout JP (2008). Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J Neuroinflammation, 5:15.
62. Dantzer R, O'Connor JC, Lawson MA, Kelley KW (2011). Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology, 36:426-436.
63. Oxenkrug G, Perianayagam M, Mikolich D, Requintina P, Shick L, Ruthazer R, Zucker D, Summergrad P (2011). Interferon-gamma (+874) T/A genotypes and risk of IFN-alpha-induced depression. J Neural Transm, 118:271-274
64. Pitche PT (2005). Sante,15:205-208.
65. Belmaker, RH and Agam G (2008). Major depressive disorder, N Engl J Med, 358: 55-68.
66. Zhdanova IV, Masuda K, Quasarano-Kourkoulis C, Rosene DL, Killiany RJ, Wang S (2011). Aging of intrinsic circadian rhythms and sleep in a diurnal nonhuman primate, Macaca mulatta. J Biol Rhythms, 26:149-159
67. Kenis G, Prickaerts J, J van Os (2010). Depressive symptoms following interferon-alpha therapy: mediated by immune-induced reductions in brain-derived neurotropic factor. Inter J Neuropsychpharmacol, 1 -7
68. Orlikov AB, Prakhye IB, Ryzov IV (1994). Kynurenine in blood and DST in patients with endogenus anxiety and endogenous depression. Biol Psychiatry, 36:97-102.
69. Dilman VM, Lapin IP, Oxenkrug GF (1979). Serotonin and aging. In Serotonin in health and disease. Essman W - ed, Spectrum Press, NY-London, Vol. 5: 111-123
70. Miller CL, Llenos IC, Dulay JR, Weis S (2006). Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulated cortex from individuals with schizophrenia and bipolar disorder. Brain Res, 1073-1074:25-37.
71. Wonodi I and Schwarcz R (2010). Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia. , 36:211-8
72. Jang SW, Liu X, Pradoldej S, Tosini G, Chang Q, Iuvone PM, Ye K (2010). N-acetylserotonin activates TrkB receptor in a circadian rhythm. Proc Natl Acad Sci U S A,107: 3876-3881.
73. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O, Belzung C, Hen R (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science. 301:805-809.
74. Fernandes BS, Gama CS, Ceresér KM, Yatham LN, Fries GR, Colpo G, de Lucena D, Kunz M, Gomes FA, Kapczinski F (2011). Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: A systematic review and meta-regression analysis. J Psychiatr Res, 45:995-1004
75. Oxenkrug GF (2004). Anti-Aging Effect of (-) Deprenyl and Inhibition of Lipid Peroxidation by N- acetylserotonin and Mating (a mini-review). In: Monoamine Oxidase inhibitors and their role in neurotransmission (drug development); (T.Torok & I. Klebovich -eds.), Medicina Publishing House Co., Budapest, pp 309-319.
76. Oxenkrug GF (2005). Antioxidant effects of N-acetylserotonin: possible mechanisms and clinical implications. Ann. N Y Acad. Sci, 1053: 334-347.
77. Oxenkrug GF, Requintina PJ, Bachurin S (2001). Antioxidant and anti-aging activity of N-acetylserotonin in the in vivo and in vitro models. Ann. New York Acad. Sci, 939:190-199.
78. Oxenkrug GF (1998). N-acetylserotonin and the hypotensive effect of MAO-A inhibition (mini-review). Vopr. Med. Khim, 43:522-526, (Russian).
79. Oxenkrug GF (1999). Antidepressive and antihypertensive effects of MAO-A inhibition: role of N-acetylserotonin. Neurobiology, 7:213-224
80. Oxenkrug GF (2005). Antidepressant effect of N-acetylserotonin in relation to aging, hypertension and cancer. In: Hormones, age and cancer (L. Berstein - ed), Nauka, St.Petersburg, pp. 140-158
81. Oxenkrug GF, Requintina PJ, McIntyre IM, Davis R (1991). Stimulation of rat pineal melatonin synthesis by a single electroconvulsive shock: chronobiological effect of antidepressant therapy? In 5-hydroxytryptamine in Psychiatry: A spectrum of Ideas. (M. Sandler, A Coppen and S Harnett - eds.), Oxford University Press, pp: 110-115
82. Prakhie IV and Oxenkrug GF (1998). The effect of nifedipine on activity of MAO inhibitors, N-acetylserotonin and melatonin in the mouse tail suspension test. Int J Neuropsychopharmacol, 1:35-40
83. Oxenkrug GF, Bachurin SO, Prakhie IV, Zefirov NS (2010) Quinone reductase 2 and antidepressant effect of melatonin derivatives. Ann N Y Acad Sci, 1199: 121-124
84. McIntyre IM and Oxenkrug GF (1991). Effect of aging on melatonin biosynthesis induced by 5-hydroxytryptophan and constant light on rats. Prog. Neuro-Psychopharmacol.& Biol. Psychiat, 15:561-566.
85. Capuron L, Schroecksnadel S, Féart C, Aubert A, Higueret D, Barberger-Gateau P, Layé S, Fuchs D (2011). Chronic Low-Grade Inflammation in Elderly Persons Is Associated with Altered Tryptophan and Tyrosine Metabolism: Role in Neuropsychiatric Symptoms. Biol Psychiatry, 70:175-82
86. Guillemin GJ and Brew BJ (2002). Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease. Redox Rep,7:199-206.
87. Leonard B (2007). Inflammation, depression and dementia: are they connected? Neurochem Res, 32:1749 -1756
88. Rosczyk HA, Sparkman NL, Johnson RW (2008). Neuroinflammation and cognitive function in aged mice following minor surgery. Exp Gerontol, 43:840-846.
89. Chrapko W, Jurasz P, Radomski MW, Archer SL, Newman SC, Baker G, Lara N, Le Mellédo JM (2006). Alteration of decreased plasma NO metabolites and platelet NO synthase activity by paroxetine in depressed patients. Neuropsychopharmacology, 31:1286-1293.
90. Manev G. and Manev R (2007). 5-lipoxygenase as a possible biological link between depressive symptoms and atherosclerosis. Arch Gen Psychiatry, 64: 1333 -1334
91. Finkelstein JA (1982). Brain serotonergic activity and plasma amino acid levels in genetically obese Zucker rats.Pharmacol Biochem Behav, 17:939-944.
92. Brandacher G, et al (2006a). Bariatric surgery cannot prevent tryptophan depletion due to chronic immune activation in morbidly obese patients. Obes Surg, 16:541-548
93. Breum L, Rasmussen MH, Hilsted J, Fernstrom JD (2003). Twenty-four-hour plasma tryptophan concentrations and ratios are below normal in obese subjects and are not normalized by substantial weight reduction. Am J Clin Nutr, 77:1112-1118.
94. Hasegawa-Ishii S, Takei S, Inaba M, Umegaki H, Chiba Y, Furukawa A, Kawamura N, Hosokawa M, Shimada A (2011). Defects in cytokine-mediated neuroprotective glial responses to excitotoxic hippocampal injury in senescence-accelerated mouse. Brain Behav Immun, 25:83-100.
95. Gramsbergen JB, Schmidt W, Turski WA, Schwarcz R (1992). Age-related changes in kynurenic acid production in rat brain. Brain Res, 588:1-5.
96. Moroni F, Russi P, Carlá V, Lombardi G (1998). Kynurenic acid is present in the rat brain and its content increases during development and aging processes. Neurosci Lett, 94, 145-150.
97. Urbanska EM, Luchowski P, Luchowska E, Pniewski J, Wozniak R, Chodakowska-Zebrowska M, Lazarewicz J (2006). Serum kynurenic acid positively correlates with cardiovascular disease risk factor, homocysteine: a study in stroke patients. Pharmacol Rep, 58:507-511
98. Frick B, Schroecksnadel K, Neurauter G (2004). Increasing production of homocysteine and neopterin and degradation of tryptophan with older age. Clin. Biochem, 37,684-687.
99. Niinisalo P, Raitala A, Pertovaara M, Oja SS, Lehtimäki T, Kähönen M, Reunanen A, Jula A, Moilanen L, Kesäniemi YA, Nieminen MS, Hurme M (2008). Indoleamine 2,3-dioxygenase activity associates with cardiovascular risk factors: the Health 2000 study. Scand J Clin Lab Invest, 68:767-770.
100. Pertovaara M, Raitala A, Lehtimäki T, Karhunen PJ, Oja SS, Jylhä M, Hervonen A, Hurme M (2006). Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality. Mech Ageing Dev, 127 :497-499.
101. Fahey JL, Schnelle JF, Boscardin J, Thomas JK, Gorre ME, Aziz N, Sadeghi H, Nishanian P (2000). Distinct categories of immunologic changes in frail elderly Mech Ageing Dev,15:1-20
102. Spencer ME, Jain A, Matteini A, Beamer BA, Wang NY, Leng SX, Punjabi NM, Walston JD, Fedarko NS. (2010). Serum levels of the immune activation marker neopterin change with age and gender and are modified by race, BMI, and percentage of body fat. J Gerontol A Biol Sci Med Sci, 65:858-865.
103. Grammer TB, Fuchs D, Boehm BO, Winkelmann BR, Maerz W (2009). Neopterin as a predictor of total and cardiovascular mortality in individuals undergoing angiography in the Ludwigshafen Risk and Cardiovascular Health study. Clin Chem, 55:1135-1146.
104. Ledochowski M, Murr C, Widner B, Fuchs D (1999). Association between insulin resistance, body mass and neopterin concentrations. Clin Chim Acta, 282: 115-123.
105. Oxenkrug G, Tucker K, Requintina P, Summergrad P (2011). Neopterin, a marker of interferon-gamma-inducible inflammation, correlates with pyridoxal-5'-phosphate, waist circumference, HDL-cholesterol, insulin resistance and mortality risk in adult Boston community dwellers of Puerto Rican origin. American Journal of Neuroprotection and Neuroregeneration, 3: 48 -52.
106. Morris MS, Sakakeeny L, Jacques PF, Picciano MF, Selhub J (2010). Vitamin B-6 intake is inversely related to, and the requirement is affected by, inflammation status. J Nutr, 140:103-110.
107. Shen J, Lai CQ, Mattei J, Ordovas JM, Tucker KL (2010). Association of vitamin B-6 status with inflammation, oxidative stress, and chronic inflammatory conditions: the Boston Puerto Rican Health Study. Am J Clin Nutr, 91:337-342.
108. Rudzite V, Jurica E, Fuchs D, Kalnins U, Erglis A, Trusinskis K (2005). Inflammation, homocysteine, pyridoxal-5-phosphate and lipids in patients with coronary artery disease before and six months after coronary angioplasty followed by stent implantation. Pteridines 16: 190-194.
109. Campayo A, de Jonge P, Roy JF, Saz P, de la Cámara C, Quintanilla MA, Marcos G, Santabárbara J, Lobo A; ZARADEMP Project (2010). Depressive disorder and incident diabetes mellitus: the effect of characteristics of depression. Am J Psychiatry, 167:580-588.
110. White RE, Gerrity R, Barman SA, Han G (2010). Estrogen and oxidative stress: A novel mechanism that may increase the risk for cardiovascular disease in women. Steroids, 75:788-793.